MetaCenTherapeutics

BiotechnologySeries BGyeonggi-do, South Koreametacen.com

Latest round

Series B

Last raised

Apr 2021

Total raised

$9.3M

Investors

6

About MetaCenTherapeutics

, Ltd, doing business as MetaCenTherapeutics, operates as a biotechnology firm that develops drugs used to treat metabolic diseases, as well as a manufacturer of medical food. MetaCenTherapeutics is a developer of a business collaboration system aimed at delivering safe therapeutic products with precise instructions. Furthermore, the company provides medical food, skincare, and drug solutions in disease areas where there are significant unmet needs, allowing clients to achieve professional products that lead the innovative market. The company's pharmaceutical products decompose and discharge sugar toxins that are produced in or introduced into the body.

Who invested in MetaCenTherapeutics

6 investors across 3 rounds

See all investors in MetaCenTherapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Apr 15, 2021

    Amount

    $5.6M

    Investors

    Locked

  2. Series A

    Feb 28, 2017

    Amount

    $2.8M

    Investors

    Locked

  3. Seed

    Aug 20, 2016

    Amount

    $0.9M

    Investors

    Locked

Questions about MetaCenTherapeutics

Who invested in MetaCenTherapeutics?

MetaCenTherapeutics has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has MetaCenTherapeutics raised?

MetaCenTherapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did MetaCenTherapeutics last raise money?

MetaCenTherapeutics's most recent round on record is a Series B, in Apr 2021.

What does MetaCenTherapeutics do?

, Ltd, doing business as MetaCenTherapeutics, operates as a biotechnology firm that develops drugs used to treat metabolic diseases, as well as a manufacturer of medical food.

Where is MetaCenTherapeutics headquartered?

MetaCenTherapeutics is headquartered in Gyeonggi-do, South Korea.

Which VCs invest in companies like MetaCenTherapeutics?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at MetaCenTherapeutics's stage. Their profiles are linked below.

Raising like MetaCenTherapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.